首页 | 本学科首页   官方微博 | 高级检索  
     

Vasostatin重组腺病毒的构建和体外表达的研究
引用本文:丁振宇,杨莉,田聆,刘芬,肖飞,魏于全. Vasostatin重组腺病毒的构建和体外表达的研究[J]. 四川大学学报(医学版), 2004, 35(4): 460-462,469
作者姓名:丁振宇  杨莉  田聆  刘芬  肖飞  魏于全
作者单位:四川大学华西医院,人类疾病生物治疗教育部重点实验室肿瘤中心,成都,610041;四川大学华西医院,人类疾病生物治疗教育部重点实验室肿瘤中心,成都,610041;四川大学华西医院,人类疾病生物治疗教育部重点实验室肿瘤中心,成都,610041;四川大学华西医院,人类疾病生物治疗教育部重点实验室肿瘤中心,成都,610041;四川大学华西医院,人类疾病生物治疗教育部重点实验室肿瘤中心,成都,610041;四川大学华西医院,人类疾病生物治疗教育部重点实验室肿瘤中心,成都,610041
基金项目:国家自然科学基金 (批准号 3 0 13 0 2 60 )资助
摘    要:目的构建vasostatin重组腺病毒表达载体,并进行体外表达研究。方法根据GenBank中提供的钙网蛋白序列,设计并合成引物,以人骨骼肌cDNA文库为模板用PCR扩增出人vasostatin基因,将其克隆入T载体。经酶切及测序鉴定后亚克隆至穿梭载体,与经过限制酶处理的骨架腺病毒载体DNA—TPC复合物共转染293细胞。用Western blot检测体外表达。结果PCR扩增出约590bp产物,测序结果与文献报道一致。用PCR及Western blot证实重组腺病毒构建成功,能有效的表达出vasostatin蛋白。结论vasostatin重组腺病毒载体能有效的在体外表达出vasostatin蛋白。

关 键 词:vasostatin  腺病毒  基因治疗
修稿时间:2004-02-09

Construction of Recombinant Adenovirus for the Angiogenic Inhibitor,Vasostatin,and Its Expression in vitro
Zhen-yu Ding,Li Yang,Ling Tian,Fen Liu,Fei Xiao,Yu-quan We. Construction of Recombinant Adenovirus for the Angiogenic Inhibitor,Vasostatin,and Its Expression in vitro[J]. Journal of Sichuan University. Medical science edition, 2004, 35(4): 460-462,469
Authors:Zhen-yu Ding  Li Yang  Ling Tian  Fen Liu  Fei Xiao  Yu-quan We
Affiliation:Key Laboratory of Biotherapy of Human Diseases of Ministry of Education, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
Abstract:Objective To construct a recombinant replication deficient adenovirus for the angiogenic inhibitor, vasostatin and assay its expression in vitro. Methods The cDNA for vasostatin was got by PCR amplification, then it was cloned into T vector and confirmed by enzymatic analysis and direct sequencing. Subsequently the cDNA was subcloned into the shuttle plasmid, and co transformed into 293 cells with backbone plasmid. The resulting recombinant andenovirus was confirmed by PCR and western blot. The activity was assayed by inhibition of HUVEC growth. Results The PCR product was about 590 bp in length, and sequencing result was identical to that reported. The construction of recombinant replication deficient adenovirus was confirmed by PCR. Western blot analysis showed the expression of vasostatin in vitro. The supernatant from transduced HeLa cells inhibited the growth of HUVEC specifically. Conclusion The recombinant adenovirus for vasostatin efficiently mediated the expression of the protein in vitro.
Keywords:Vasostatin Adenovirus vector Gene therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号